News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Point72 Asset Management, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.2% stake in Cepton, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Progress Acquisition Corp. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.2% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 4.4% stake in Axogen, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.6% stake in BellRing Brands, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Otonomy, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.2% stake in Atara Biotherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Minerva Neurosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.9% stake in Arcutis Biotherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Merrimack Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 3.2% stake in Applied Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.2% stake in Akero Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.2% stake in Krystal Biotech, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.8% stake in Affimed N.V. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.9% stake in Intercept Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 3.6% stake in Achilles Therapeutics plc |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Blue Owl Capital Inc. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 9.1% stake in Mereo BioPharma Group plc |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 7.5% stake in Krystal Biotech, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Kadmon Holdings, Inc. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 8.6% stake in Growth Capital Acquisition Corp. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 8% stake in Oyster Point Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.4% stake in Paya Holdings Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 1.1% stake in Poshmark, Inc. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 6.5% stake in Cidara Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 5.3% stake in Bicycle Therapeutics plc |
|
|
|